메뉴 건너뛰기




Volumn 15, Issue 3, 2009, Pages 291-295

Rethinking TNM: A breast cancer classification to guide to treatment and facilitate research

Author keywords

Biologic variables; Breast cancer; TNM classification

Indexed keywords

BEVACIZUMAB; TRASTUZUMAB;

EID: 65549117451     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00719.x     Document Type: Article
Times cited : (50)

References (8)
  • 2
    • 32244442475 scopus 로고    scopus 로고
    • Rethinking TNM: Breast cancer TNM classification for treatment decision-making and research
    • DOI 10.1016/j.breast.2005.11.011, PII S0960977605002973
    • Veronesi U, Viale G, Rotmensz N, Goldhirsch A. Rethinking TNM: Breast cancer TNM classification for treatment decision-making and research. Breast 2006 15 : 3 8. (Pubitemid 43210543)
    • (2006) Breast , vol.15 , Issue.1 , pp. 3-8
    • Veronesi, U.1    Viale, G.2    Rotmensz, N.3    Goldhirsch, A.4
  • 3
    • 0031941465 scopus 로고    scopus 로고
    • Ductal carcinoma in situ: Introduction of the concept of ductal intraepithelial neoplasia
    • Tavassoli FA. Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 1998 11 : 140 54. (Pubitemid 28144150)
    • (1998) Modern Pathology , vol.11 , Issue.2 , pp. 140-154
    • Tavassoli, F.A.1
  • 4
    • 0035884636 scopus 로고    scopus 로고
    • Meeting highlights: International Consensus Panel on the treatment of primary breast cancer. Seventh international conference on adjuvant therapy of primary breast cancer
    • Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn H. Meeting highlights: International Consensus Panel on the treatment of primary breast cancer. Seventh international conference on adjuvant therapy of primary breast cancer. J Clin Oncol 2001 19 : 3817 27.
    • (2001) J Clin Oncol , vol.19 , pp. 3817-27
    • Goldhirsch, A.1    Glick, J.H.2    Gelber, R.D.3    Coates, A.S.4    Senn, H.5
  • 5
    • 34547852275 scopus 로고    scopus 로고
    • Progress and promise: Highlights of the international expert consensus on the primary therapy of early breast cancer 2007
    • DOI 10.1093/annonc/mdm271
    • Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn HJ. 10th St. Gallen conference. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007 18 : 1133 44. (Pubitemid 47244357)
    • (2007) Annals of Oncology , vol.18 , Issue.7 , pp. 1133-1144
    • Goldhirsch, A.1    Wood, W.C.2    Gelber, R.D.3    Coates, A.S.4    Thurlimann, B.5    Senn, H.-J.6
  • 6
    • 41649108476 scopus 로고    scopus 로고
    • Potential for false-positive staining with a rabbit monoclonal antibody to progesterone receptor (SP2): Findings of the UK National External Quality Assessment Scheme for immunocytochemistry and FISH highlight the need for correct validation of antibodies on introduction to the laboratory
    • Ibrahim M, Dodson A, Barnett S, Fish D, Jasani B, Miller K. Potential for false-positive staining with a rabbit monoclonal antibody to progesterone receptor (SP2): findings of the UK National External Quality Assessment Scheme for immunocytochemistry and FISH highlight the need for correct validation of antibodies on introduction to the laboratory. Am J Clin Pathol 2008 129 : 398 409.
    • (2008) Am J Clin Pathol , vol.129 , pp. 398-409
    • Ibrahim, M.1    Dodson, A.2    Barnett, S.3    Fish, D.4    Jasani, B.5    Miller, K.6
  • 7
    • 19944430195 scopus 로고    scopus 로고
    • Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy
    • Viale G, Maiorano E, Pruneri G, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005 241 : 319 25.
    • (2005) Ann Surg , vol.241 , pp. 319-25
    • Viale, G.1    Maiorano, E.2    Pruneri, G.3
  • 8
    • 0033048939 scopus 로고    scopus 로고
    • Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system
    • Jacobs TW, Gown AM, Yaziji H, Barnes MJ, Schnitt SJ. Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol 1999 17 : 1983 7. (Pubitemid 29318825)
    • (1999) Journal of Clinical Oncology , vol.17 , Issue.7 , pp. 1983-1987
    • Jacobs, T.W.1    Gown, A.M.2    Yaziji, H.3    Barnes, M.J.4    Schnitt, S.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.